Thermo Fisher Scientific Inc. announced that it has completed the acquisition of TKA Wasseraufbereitungssysteme GmbH, a European provider of laboratory water purification systems.
A collaborative team of scientists and physicians at the Medical College of Wisconsin and Children's Hospital of Wisconsin uses genetic sequencing to identify and treat an unknown disease.
Scientists from Imperial College London are developing technology that could ultimately sequence a person's genome in mere minutes, at a fraction of the cost of current commercial techniques.
In the latest of a series of related papers, researchers present a new and more definitive explanation of how fibrotic cells form, multiply and eventually destroy the human liver, resulting in cirrhosis.
An over-the-counter herbal treatment believed to have medicinal benefits has minimal impact in relieving the common cold, according to research by the University of Wisconsin-Madison School of Medicine and Public Health.
Cyclacel Pharmaceuticals, Inc. provided topline results from APPRAISE, a Phase 2b, randomized discontinuation, double-blinded, placebo-controlled, study of oral seliciclib capsules as a third or more line treatment in patients with non-small cell lung cancer.
VBL Therapeutics announced the initiation of a phase 2 study to evaluate the efficacy and safety of its lead compound, VB-201, among patients with elevated high sensitivity C-reactive protein who are currently taking statins.
Vivus Inc. said it asked European regulators to approve its weight-loss drug Qnexa, which has already been rejected by U.S. regulators because of concerns over links to potential heart problems and birth defects.
Incyte Corp. said its primary drug candidate succeeded in a late-stage clinical trial that tested the drug as a treatment for myelofibrosis, a cancer of the blood.
AstraZeneca PLC said it has stopped development of its drug motavizumab for preventing serious respiratory syncytial virus disease but would continue working on other applications.
Drug developer Pfizer Inc. recalled a batch of 19,000 bottles of the blockbuster cholesterol drug Lipitor, citing a consumer complaint about an "uncharacteristic" odor.
Eli Lilly and Co. has completed its purchase of Avid Radiopharmaceuticals Inc. for $300 million and said the Food and Drug Administration will perform a faster review of florbetapir, an imaging agent Avid developed that may help diagnose Alzheimer's disease.
PharmaNet Development Group, Inc. announced that its regulatory and pharmaceutical development experts are available to offer guidance on the regulatory pathway for biosimilar development in the United States, following a recent FDA hearing.
The integration of the Coherent Chameleon Compact OPO with the Leica TCS SP5 MP confocal and multiphoton microscope allows observation of fast dynamic processes in living cells with deep penetration at high resolution with one integrated microscope system.
Life Technologies Corporation, a provider of innovative life science solutions, announced that it has launched its Ion Personal Genome Machine (PGM) sequencer, the first product to use semiconductor sequencing technology.